The original article can be found here.
Article highlights:
- Aspen needs clear commitments within weeks from African governments for orders of its Covid-19 vaccine or will recommit that production line in Gqeberha to more in-demand anesthetics.
- “We had counted on, and were assured, that the regional manufacturing platform was critical and would be supported. We had banked on these initial volumes to give us the time to enable us to pivot to other vaccines.” – Stavros Nicolaou.
- The situation is a setback for Africa’s plans to catch up with more developed countries’ Covid-19 vaccination rates, and prepare for the possibility of future pandemics.
